Inactivation of TIF1γ cooperates with KrasG12D to induce cystic tumors of the pancreas

PLoS Genetics

Volumn 5, Issue 7, 2009, Pages

  Vincent, David F ^a,b,d   Yan, Kai Ping ^c,h   Treilleux, Isabelle ^d   Gay, Fabien ^a   Arfi, Vanessa ^a,b,d   Kaniewsky, Bastien ^a,b,d   Marie, Julien C ^a   Lepinasse, Florian ^a,b,e   Martel, Sylvie ^a,d   Goddard Leon, Sophie ^d   Iovanna, Juan L ^a   Dubus, Pierre ^f   Garcia, Stéphane ^a   Puisieux, Alain ^a,b,d   Rimokh, Ruth ^a,b   Bardeesy, Nabeel ^g   Scoazec, Jean Yves ^a,b,e   Losson, Régine ^c   Bartholin, Laurent ^a,b,d  

^a INSERM   (France)

^b UNIVERSITÉ DE LYON   (France)

^c INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^d CENTRE LÉON BÉRARD   (France)

^e EDOUARD HERRIOT HOSPITAL   (France)

^f UNIVERSITÉ DE BORDEAUX   (France)

^g HARVARD MEDICAL SCHOOL   (United States)

^h WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; SMAD4 PROTEIN; TRANSCRIPTION FACTOR PDX 1; TRANSCRIPTIONAL INTERMEDIARY FACTOR 1 GAMMA; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; KRAS2 PROTEIN, MOUSE; PROTEIN P21; TRANSCRIPTION FACTOR; TRIM33 PROTEIN, HUMAN; TRIM33 PROTEIN, MOUSE;

ANALYSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CONTROLLED STUDY; DEVELOPMENT; DOWN REGULATION; ENDOCRINE CELL; GENE; GENE ACTIVATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; INTROSPECTION; KNOCKOUT MOUSE; KRAS GENE; MOUSE; NONHUMAN; ONCOGENE; PANCREAS; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS ISLET CELL; PRECANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; METABOLISM; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; TUMOR SUPPRESSOR GENE;

MUS;

ANIMALS; CARCINOMA, PANCREATIC DUCTAL; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS P21(RAS); TRANSCRIPTION FACTORS;

EID: 68249108045     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1000575     Document Type: Article

References (48)

1. Maitra A, Hruban RH (2008) Pancreatic cancer. Annu Rev Pathol 3: 157-188.
2. Maitra A, Fukushima N, Takaori K, Hruban RH (2005) Precursors to invasive pancreatic cancer. Adv Anat Pathol 12: 81-91.
3. Furukawa T, Kloppel G, Volkan Adsay N, Albores-Saavedra J, Fukushima N, et al. (2005) Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 447: 794-799. (Pubitemid 41728866)
4. Koorstra JB, Hustinx SR, Offerhaus GJ, Maitra A (2008) Pancreatic carcinogenesis. Pancreatology 8: 110-125.
5. Bardeesy N, DePinho RA (2002) Pancreatic cancer biology and genetics. Nature Reviews Cancer 2: 897-909.
6. Shi C, Hruban RH, Klein AP (2009) Familial pancreatic cancer. Arch Pathol Lab Med 133: 365-374.
7. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, et al. (2006) Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66: 95-106. (Pubitemid 43166014)
8. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450. (Pubitemid 38050041)
9. Guerra C, Schuhmacher AJ, Canamero M, Grippo PJ, Verdaguer L, et al. (2007) Chronic pancreatitis is essential for induction of pancreatic ductal adenocarcinoma by K-Ras oncogenes in adult mice. Cancer Cell 11: 291-302. (Pubitemid 46349841)
10. Grippo PJ, Nowlin PS, Demeure MJ, Longnecker DS, Sandgren EP (2003) Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. Cancer Research 63: 2016-2019.
11. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7: 469-483. (Pubitemid 40719130)
12. Aguirre AJ, Bardeesy N, Sinha M, Lopez L, Tuveson DA, et al. (2003) Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma. Genes & Development 17: 3112-3126. (Pubitemid 38040774)
13. Bardeesy N, Aguirre AJ, Chu GC, Cheng KH, Lopez LV, et al. (2006) Both p16(Ink4a) and the p19(Arf)-p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse. Proc Natl Acad Sci U S A 103: 5947-5952.
14. Ijichi H, Chytil A, Gorska AE, Aakre ME, Fujitani Y, et al. (2006) Aggressive pancreatic ductal adenocarcinoma in mice caused by pancreas-specific blockade of transforming growth factor-beta signaling in cooperation with active Kras expression. Genes Dev 20: 3147-3160. (Pubitemid 44790629)
15. Hezel AF, Gurumurthy S, Granot Z, Swisa A, Chu GC, et al. (2008) Pancreatic LKB1 deletion leads to acinar polarity defects and cystic neoplasms. Mol Cell Biol 28: 2414-2425.
16. Siveke JT, Einwachter H, Sipos B, Lubeseder-Martellato C, Kloppel G, et al. (2007) Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 12: 266-279. (Pubitemid 47333415)
17. De La OJ-P, Emerson LL, Goodman JL, Froebe SC, Illum BE, et al. (2008) Notch and Kras reprogram pancreatic acinar cells to ductal intraepithelial neoplasia. Proc Natl Acad Sci U S A 105: 18907-18912. Epub 12008 Nov 18921.
18. Nolan-Stevaux O, Lau J, Truitt ML, Chu GC, Hebrok M, et al. (2009) GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 23: 24-36.
19. Shi G, Zhu L, Sun Y, Bettencourt R, Damsz B, et al. (2009) Loss of the Acinar- Restricted Transcription Factor Mist1 Accelerates Kras-Induced Pancreatic Intraepithelial Neoplasia. Gastroenterology 136(4): 1368-1378.
20. Jones S, Zhang X, Parsons DW, Lin JC, Leary RJ, et al. (2008) Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 321: 1801-1806.
21. Bardeesy N, Cheng KH, Berger JH, Chu GC, Pahler J, et al. (2006) Smad4 is dispensable for normal pancreas development yet critical in progression and tumor biology of pancreas cancer. Genes Dev 20: 3130-3146. (Pubitemid 44790628)
22. Izeradjene K, Combs C, Best M, Gopinathan A, Wagner A, et al. (2007) Kras(G12D) and Smad4/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas. Cancer Cell 11: 229-243. (Pubitemid 46349845)
23. Kojima K, Vickers SM, Adsay NV, Jhala NC, Kim HG, et al. (2007) Inactivation of Smad4 accelerates Kras(G12D)-mediated pancreatic neoplasia. Cancer Res 67: 8121-8130. (Pubitemid 47395147)
24. Kuang C, Xiao Y, Liu X, Stringfield TM, Zhang S, et al. (2006) In vivo disruption of TGF-beta signaling by Smad7 leads to premalignant ductal lesions in the pancreas. Proc Natl Acad Sci U S A 103: 1858-1863.
25. Ross S, Hill CS (2008) How the Smads regulate transcription. Int J Biochem Cell Biol 40: 383-408.
26. Massague J, Gomis RR (2006) The logic of TGFbeta signaling. FEBS Lett 580: 2811-2820.
27. Venturini L, You J, Stadler M, Galien R, Lallemand V, et al. (1999) TIF1gamma, a novel member of the transcriptional intermediary factor 1 family. Oncogene 18: 1209-1217. (Pubitemid 29085994)
28. Yan KP, Dolle P, Mark M, Lerouge T, Wendling O, et al. (2004) Molecular cloning, genomic structure, and expression analysis of the mouse transcriptional intermediary factor 1 gamma gene. Gene 334: 3-13. (Pubitemid 38902710)
29. Dupont S, Zacchigna L, Cordenonsi M, Soligo S, Adorno M, et al. (2005) Germ-layer specification and control of cell growth by Ectodermin, a Smad4 ubiquitin ligase. Cell 121: 87-99. (Pubitemid 40501170)
30. Dupont S, Mamidi A, Cordenonsi M, Montagner M, Zacchigna L, et al. (2009) FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136: 123-135.
31. Levy L, Howell M, Das D, Harkin S, Episkopou V, et al. (2007) Arkadia activates Smad3/Smad4-dependent transcription by triggering signal-induced SnoN degradation. Mol Cell Biol 27: 6068-6083. (Pubitemid 47326695)
32. He W, Dorn DC, Erdjument-Bromage H, Tempst P, Moore MA, et al. (2006) Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the TGFbeta pathway. Cell 125: 929-941. (Pubitemid 43795187)
33. Doisne JM, Bartholin L, Yan KP, Garcia CN, Duarte N, et al. (2009) iNKT cell development is orchestrated by different branches of TGF-beta signaling. J Exp Med 206: 1365-1378.
34. Gu G, Dubauskaite J, Melton DA (2002) Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. Development 129: 2447-2457. (Pubitemid 34863851)
35. Jorgensen MC, Ahnfelt-Ronne J, Hald J, Madsen OD, Serup P, et al. (2007) An illustrated review of early pancreas development in the mouse. Endocr Rev 28: 685-705. (Pubitemid 47606652)
36. Erdogan M, Pozzi A, Bhowmick N, Moses HL, Zent R (2008) Transforming growth factor-beta (TGF-beta) and TGF-beta-associated kinase 1 are required for R-Ras-mediated transformation of mammary epithelial cells. Cancer Res 68: 6224-6231.
37. Heldin CH, Moustakas A (2006) A new twist in Smad signaling. Dev Cell 10: 685-686.
38. Ng YY, Fan JM, Mu W, Nikolic-Paterson DJ, Yang WC, et al. (1999) Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 14: 2860-2872.
39. Sawyer JR, Thomas EL, Lukacs JL, Swanson CM, Ding Y, et al. (2002) Recurring breakpoints of 1p13 approximately p22 in osteochondroma. Cancer Genet Cytogenet 138: 102-106. (Pubitemid 36020463)
40. Johansson M, Dietrich C, Mandahl N, Hambraeus G, Johansson L, et al. (1994) Karyotypic characterization of bronchial large cell carcinomas. Int J Cancer 57: 463-467. (Pubitemid 24173087)
41. Klugbauer S, Rabes HM (1999) The transcription coactivator HTIF1 and a related protein are fused to the RET receptor tyrosine kinase in childhood papillary thyroid carcinomas. Oncogene 18: 4388-4393. (Pubitemid 29392380)
42. Khetchoumian K, Teletin M, Tisserand J, Mark M, Herquel B, et al. (2007) Loss of Trim24 (Tif1alpha) gene function confers oncogenic activity to retinoic acid receptor alpha. Nat Genet 39: 1500-1506. (Pubitemid 350191338)
43. Jackson EL, Willis N, Mercer K, Bronson RT, Crowley D, et al. (2001) Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras. Genes & Development 15: 3243-3248. (Pubitemid 34008190)
44. Johnson L, Mercer K, Greenbaum D, Bronson RT, Crowley D, et al. (2001) Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.[see comment]. Nature 410: 1111-1116.
45. Tuveson DA, Shaw AT, Willis NA, Silver DP, Jackson EL, et al. (2004) Endogenous oncogenic K-ras(G12D) stimulates proliferation and widespread neoplastic and developmental defects. Cancer Cell 5: 375-387.
46. Treilleux I, Blay JY, Bendriss-Vermare N, Ray-Coquard I, Bachelot T, et al. (2004) Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 10: 7466-7474. (Pubitemid 39561754)
47. Albores-Saavedra J, Weimersheimer-Sandoval M, Chable-Montero F, Montante- Montes de Oca D, Hruban RH, et al. (2008) The foamy variant of pancreatic intraepithelial neoplasia. Ann Diagn Pathol 12: 252-259.
48. Bartholin L, Cyprian FS, Vincent D, Garcia CN, Martel S, et al. (2008) Generation of mice with conditionally activated transforming growth factor beta signaling through the TbetaRI/ALK5 receptor. Genesis 46(12): 724-731.